BridgeMD
New treatment option for Head and Neck Squamous Cell Carcinoma
Official title Thermotherapy in Addition to SOC Palliative Radiotherapy
ClinicalTrials.gov ID: NCT06659146
What this study is testing
- What it's testing
- This study aims to investigate the efficacy and safety profile of superficial hyperthermia (wIRA) in addition to standard of care (SOC) palliative radiotherapy in patients with inoperable/incurable locally advanced or recurrent/metastatic HNSCC or cutaneous SCC superficial tumours not suitable for radical treatment. The investigators will assess the best objective response rate (ORR) of patients with Inoperable/incurable or recurrent/metastatic HNSCC or cSCC with superficial lesion(s) treated with the combination of superficial hyperthermia (wIRA) and palliative radiotherapy.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient with histologically confirmed incurable or inoperable cancers with disease [at least one superficial lesion(s) or lymph node(s)] suitable for...
- Patient undergoing standard of care palliative radiotherapy (suitable with the pre-specified dose and fractionation in the protocol
- Aged ≥18 years old
- Eastern Cooperative Oncology Group (ECOG) performance status 0 to 1
- Patient with capacity to consent
You likely can't join if
- No superficial tumour lesion or lymph node that is suitable for hydrosun® TWH1500 treatment.
- Patients are not suitable for one of the pre-specified palliative radiotherapy dose and fractionation
- Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the study.
The study team makes the final eligibility decision.
Where it's taking place
- London, United Kingdom
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include London, United Kingdom. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.